Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Abreva?

See the DrugPatentWatch profile for Abreva

What is Abreva, and what does it treat?

Abreva is a brand-name cold sore treatment that contains the active ingredient docosanol. It is used to shorten the duration of herpes labialis (cold sores) when applied early in an outbreak. [1]

How do you use Abreva for best results?

Abreva works best when you start treatment as soon as cold sore symptoms begin (for example, tingling, itching, or redness). Apply the medication to the affected area as directed on the product label. [1]

Is Abreva a prescription drug?

Abreva is an over-the-counter (nonprescription) medicine in many markets, including the United States. [1]

Where can I read about Abreva patents and legal/market history?

For information on patent-related issues and legal/market history tied to Abreva’s active ingredient, DrugPatentWatch.com tracks drug and patent activity across jurisdictions. [2]

Sources

  1. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
  2. https://www.drugpatentwatch.com/


Other Questions About Abreva :

Can abreva be used for cold sores? Can i use abreva for a canker sore inside the mouth? Can i use abreva for a cold sore? Can i use abreva for shingles?